Drugs
-
-
Guidance, Compliance, & Regulatory Information
-
Popular Items
-
Affordable Care Act (ACA 6004) - Bioequivalence Recommendations for Specific Products
-
Biologics Price Competition and Innovation Act of 2009 -
Drug Compliance Programs -
Guidances (Drugs) -
Newly Added Guidance Documents -
Nicotine-Containing Products -
Notice to Industry: Postmarketing Requirements - Postmarket studies and clinical trials -
Office of Compliance - The Office of Prescription Drug Promotion (OPDP)
-
Regulatory Guidance Drug Registration and Listing -
Unapproved Drugs: Drugs Marketed in the United States That Do Not Have Required FDA Approval -
Warning Letters and Notice of Violation Letters to Pharmaceutical Companies
-
-
